Steven Klosk
Directeur/Membre du Conseil chez GOLDEN ARROW MERGER CORP.
Fortune : 387 899 $ au 30/06/2024
Profil
Steven M.
Klosk currently works at Formulated Solutions LLC, as Chairman from 2021, Recipharm AB, as Director from 2021, St. Joseph's Hospital Foundation (Georgia), as Director, BioVectra, Inc., as Director from 2021, BioIVT LLC, as Director from 2021, NPS, Inc. (GA), as Director, Golden Arrow Merger Corp., as Independent Director from 2021, NJ Bio, Inc, as Director from 2021, and Lisata Therapeutics, Inc., as Independent Director from 2022.
Mr. Klosk also formerly worked at Cambrex Corp., as Chief Executive Officer & Director in 2020, Caladrius Biosciences, Inc., as Independent Director, The Genlyte Group, Inc., as Secretary & Vice President-Administration from 1988 to 1992, and Lightolier, Inc., as Vice President-Administration from 1985 to 1988.
Mr. Klosk received his undergraduate degree from Cornell University and graduate degree from New York Law School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
GOLDEN ARROW MERGER CORP.
25,00% | 15/03/2024 | 35 000 ( 25,00% ) | 386 400 $ | 30/06/2024 |
| 29/04/2024 | 432 ( 0,01% ) | 1 499 $ | 30/06/2024 |
Postes actifs de Steven Klosk
| Sociétés | Poste | Début |
|---|---|---|
| GOLDEN ARROW MERGER CORP. | Directeur/Membre du Conseil | 24/02/2021 |
| RECIPHARM AB (PUBL) | Directeur/Membre du Conseil | 01/03/2021 |
| LISATA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 15/09/2022 |
| St. Joseph's Hospital Foundation (Georgia) | Directeur/Membre du Conseil | 13/04/2009 |
| NPS, Inc. (GA) | Directeur/Membre du Conseil | - |
BioIVT LLC
 BioIVT LLC Miscellaneous Commercial ServicesCommercial Services BioIVT LLC engages in the provision of research models and value-added research services for drug discovery and development. It offers biofluids, cell products, and molecular products. The company is headquartered in Wilmington, DE. | Directeur/Membre du Conseil | 01/10/2021 |
BioVectra, Inc.
 BioVectra, Inc. Pharmaceuticals: MajorHealth Technology BioVectra, Inc. manufactures and supplies custom active pharmaceutical ingredients to the North American and European markets. It offers specialty and fine chemicals, advanced intermediates, enzymes and biomolecules, as well as provide custom synthesis and manufacturing services for the pharmaceutical, biopharmaceutical, and nutraceutical industries. The company was founded by Regis J. Duffy in 1970 and is headquartered in Charlottetown, Canada. | Directeur/Membre du Conseil | 21/10/2021 |
Formulated Solutions LLC
 Formulated Solutions LLC Medical SpecialtiesHealth Technology Formulated Solutions LLC innovates, formulates, creates and co-markets consumer brands. It focus on consumer healthcare, over-the-counter (OTC), medical device, and prescription drug production. The firm also develops custom packaging to suit product needs. The company was founded by Eric Dann on October 11, 2000 and is headquartered in Largo, FL. | Président | 01/09/2021 |
NJ Bio, Inc
 NJ Bio, Inc BiotechnologyHealth Technology NJ Bio, Inc provides integrated chemistry and biology services. The company is based in Princeton, NJ. The CEO of the company is Nareshkumar Jain. | Directeur/Membre du Conseil | 01/03/2021 |
Anciens postes connus de Steven Klosk
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Steven Klosk
| Cornell University | Undergraduate Degree |
| New York Law School | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| GOLDEN ARROW MERGER CORP. | Finance |
| LISATA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 11 |
|---|---|
Cambrex Corp.
 Cambrex Corp. Pharmaceuticals: GenericHealth Technology Cambrex Corp. engages in the provision of products, services, and technologies to accelerate and improve the development and commercialization of new and generic therapeutics. It supplies to innovator and generic pharmaceutical companies. Its products include generic and branded APIs, controlled substances, chiral compounds, high potency APIs, and advanced intermediates. The company was founded by Arthur Mendolia and Cyril C. Baldwin Jr. in 1981 and is headquartered in East Rutherford, NJ. | Health Technology |
The Genlyte Group, Inc.
 The Genlyte Group, Inc. Electrical ProductsProducer Manufacturing The Genlyte Group, Inc. designs and manufactures indoor and outdoor lighting products for the incandescent, fluorescent, emergency, high-intensity discharge (HID), down lighting, medical and commercial decorative lighting and niche markets. The company is headquartered in Burlington, MA. | Producer Manufacturing |
Recipharm AB
 Recipharm AB BiotechnologyHealth Technology Recipharm AB engages in the manufacture of pharmaceuticals and contract development services for pharmaceutical companies. It operates through the following segments: Manufacturing Sterile and Inhalation (MFG-SI); Manufacturing Solids and Others (MFG-SO); Development and Technology (D&T); and Others and Eliminations. The MFG-SI segment includes manufacturing of products on behalf of pharmaceutical companies and covers sterile and inhalation technologies as well as liquid vials and ampoules, lyophilisates, blow-fill-seal products, and inhalation. The MFG-SO segment produces products on behalf of pharmaceutical companies and covers tablets, capsules, semi-solids, and non-sterile liquids. The D&T segment focuses on pharmaceutical development services. The company was founded by Lars Rickard Backsell and Thomas Bengt Eldered in 1995 and is headquartered in Stockholm, Sweden. | Health Technology |
| Lightolier, Inc. | Producer Manufacturing |
Caladrius Biosciences, Inc.
 Caladrius Biosciences, Inc. BiotechnologyHealth Technology Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes XOWNA, CLBS12, CLBS201 and CLBS14. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ. | Health Technology |
| St. Joseph's Hospital Foundation (Georgia) | |
BioVectra, Inc.
BioVectra, Inc. Pharmaceuticals: MajorHealth Technology BioVectra, Inc. manufactures and supplies custom active pharmaceutical ingredients to the North American and European markets. It offers specialty and fine chemicals, advanced intermediates, enzymes and biomolecules, as well as provide custom synthesis and manufacturing services for the pharmaceutical, biopharmaceutical, and nutraceutical industries. The company was founded by Regis J. Duffy in 1970 and is headquartered in Charlottetown, Canada. | Health Technology |
BioIVT LLC
BioIVT LLC Miscellaneous Commercial ServicesCommercial Services BioIVT LLC engages in the provision of research models and value-added research services for drug discovery and development. It offers biofluids, cell products, and molecular products. The company is headquartered in Wilmington, DE. | Commercial Services |
Formulated Solutions LLC
Formulated Solutions LLC Medical SpecialtiesHealth Technology Formulated Solutions LLC innovates, formulates, creates and co-markets consumer brands. It focus on consumer healthcare, over-the-counter (OTC), medical device, and prescription drug production. The firm also develops custom packaging to suit product needs. The company was founded by Eric Dann on October 11, 2000 and is headquartered in Largo, FL. | Health Technology |
| NPS, Inc. (GA) | |
NJ Bio, Inc
NJ Bio, Inc BiotechnologyHealth Technology NJ Bio, Inc provides integrated chemistry and biology services. The company is based in Princeton, NJ. The CEO of the company is Nareshkumar Jain. | Health Technology |
